We have used the non-specific inhibitor of protein kinases, staurosporine, to investigate the role of protein phosphorylation during aggregation, the mobilization of intracellular Ca2" (Ca2+i) and intracellular pH (pHi) in thrombin-stimulated platelets. The concentration of staurosporine chosen for these studies, 1 ,UM, was previously reported to inhibit protein phosphorylation completely but to have no effect on the activation of phospholipase C in thrombin-stimulated human platelets [Watson, McNally, Shipman & Godfrey (1988) Biochem. J. 249, 345-350]. Aggregation induced by phorbol dibutyrate is slow (several minutes) and is inhibited completely by staurosporine. In contrast, aggregation induced by thrombin, platelet-activating factor or ionophore A23187 is rapid (occurs within 60 s), and is slowed, but not inhibited, in the presence of staurosporine. On the other hand, staurosporine causes a small potentiation of the peak [Ca2+]i signal induced by thrombin and a marked increase in the half-life of decay of this signal, but has no effect on pHi. Under conditions designed to prevent an increase in [Ca2"], (presence of Ni2" to prevent Ca2" entry, and depletion of the intracellular Ca2" stores), aggregation induced by thrombin resembles that by phorbol dibutyrate and is now inhibited completely by staurosporine. Taken together, these results provide evidence for two signalling pathways for aggregation, a relatively rapid phosphorylation-independent route mediated by Ca2" and a slower, phosphorylation-dependent, pathway mediated by protein kinase C. Since staurosporine slows aggregation induced by thrombin, it appears that under normal conditions these pathways interact synergistically.
INTRODUCTION
The activation of human platelets involves a series of biochemical changes which lead to shape change, granule secretion and aggregation. It is now generally accepted that, with thrombin, the initial event which triggers these responses is a hydrolysis of membrane inositol phospholipids, generating the two second messengers inositol 1,4,5-trisphosphate and 1,2-diacylglycerol (for review see Rink & Hallam, 1984) . Diacylglycerol, in the presence of phospholipid and cytosolic Ca2", is believed to activate protein kinase C, leading to the phosphorylation of several cellular proteins, including a 40 kDa protein of unknown function (Nishizuka, 1984) . Inositol trisphosphate stimulates Ca2" release from intracellular stores, and, in addition, Ca2l can also enter the cytoplasm across the plasma membrane through an unidentified pathway. This increase in [Ca2"], triggers a number of events, including the activation of myosin light-chain kinase and phospholipase A2; the latter leads to the release of arachidonic acid, which is rapidly converted into cyclo-oxygenase and lipoxygenase products.
The precise role of these biochemical events in the initiation of shape change, granule secretion and aggregation responses, however, is still only poorly understood. For example, although the phosphorylation of myosin light chains correlates well with the onset of shape change, there is only a poor correlation with the secretion of dense granules (Daniel et al., 1984) . More recently, several studies on semi-permeabilized platelets have further highlighted a poor agreement between protein phosphorylation and several of the responses associated with platelet activation; the relevance of many of these observations to the intact cell, however, is uncertain. Haslam & Davidson (1984) reported a poor correlation between protein phosphorylation and the secretion of 5-hydroxytryptamine from platelets permeabilized by electrical discharge and challenged with increasing concentrations of Ca2". Lapetina et al. (1985) demonstrated in saponin-permeabilized platelets that thrombin can stimulate both secretion and aggregation in the absence of protein phosphorylation. More recently still, we have been able to extend some of these observations to the intact cell, using a non-specific inhibitor of protein kinases, staurosporine (Watson et al., 1988) . We have observed thrombin-induced aggregation, albeit at a slower rate than in control tissues, in the absence of protein phosphorylation. On the other hand, staurosporine inhibited completely the secretion of 5-hydroxytryptamine and ATP, and whether this result reflects a difference between the permeabilized and intact cell preparations or an additional inhibitory action of staurosporine manifested against the secretory mechanism is not known.
The aim of the present study was to investigate the molecular basis of the staurosporine-resistant, phosphorylation-independent aggregation observed in intact platelets challenged with thrombin. Our results suggest that thrombin, and also other agonists, are able to induce platelet aggregation in the absence of phosphorylation through the mobilization of Ca2+. This pathway is potentiated by protein phosphorylation.
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Abbreviations used: [Ca'+i, intracelklar concn. ,of Ca2+; pHi; ittracellular pH; EIPA, ethylisopropylamiloride.
METHODS
Platelets were obtained from two sources: either from healthy aspirin-free volunteers on the day of the experiment, or as platelet concentrates, donated within the previous 18 h, from the Blood Transfusion Unit, John Radcliffe Hospital, Oxford. Experiments were carried on blood obtained from both sources in all cases. Plateletrich plasma was obtained from fresh blood by centrifugation at 200 g for 20 min. Platelets were loaded/ labelled with indol-AM (1.5/tM), UM) or [3H]5-hydroxytryptamine (10 ,Ci) by incubation at 37°C for 30 min (intracellular dyes) or 60 min (5-hydroxytryptamine). Platelets were subsequently isolated by centrifugation at 1000 g for 10 min in the presence of prostacyclin to raise intracellular cyclic AMP concentrations and thus prevent activation. The platelet pellet was resuspended in a modified Krebs bicarbonate buffer (composition in mM: NaCl 135, NaHCO3 12, KCI 2.8, NaH2PO4 0.35, MgCl2 1, Hepes 5, glucose 5, EGTA 1, pH 7.3); EGTA was omitted for the aggregation studies. Labelling with [32P]Pi (1 mCi/ml) was carried out at this stage by incubation at 37°C for 60 min, followed by centrifugation at 800 g in the presence of prostacyclin and resuspension. Platelets were left at least 30 min before experimentation in order to allow the actions of prostacyclin to decay. Indomethacin (10 #M) was included in the final resuspension buffer to remove any influence by cyclo-oxygenase products.
Experiments were performed in a shaking water bath, a spectrofluorimeter or, for studies involving measurements of aggregation, in a Born lumi-aggregometer. Platelet suspensions (0.5 ml) were prewarmed at 37°C for 5 min before the appropriate additions. The experiment was stopped at various times by transfer to 1.88 ml of chloroform/methanol/HCl (50:100:1, by vol.) for analyses of phosphatidic acid, to 0.5 ml of 60% (v/v) glutaraldehyde in phosphate buffer (pH 7.3) for measurements of 5-hydroxytryptamine secretion, or to Laemmli (1970) buffer for estimates of protein phosphorylation. Protein phosphorylation, phosphatidic acid and 5-hydroxytryptamine secretion were quantified as previously described (Watson et al., 1988) (Grynkiewicz et al., 1985) . These values have been measured as outlined for the use of quin2 , with corrections for the presence of extracellular dye, estimated as follows: since only extracellular dye 'sees' a rapid change in external Ca2", the difference in fluorescence made on chelating a formerly saturating concentration of Ca2" is entirely attributable to extracellular dye going from maximal to minimal fluorescence states. Estimations of pHi were made by essentially the same procedure as used for indol, with excitation and emission wavelengths of 500 and 530 nm respectively .
Phorbol dibutyrate, thrombin, indomethacin, phosphocreatine, creatine kinase, A23 187, platelet-activating factor and ADP were obtained from Sigma, Poole, Dorset, U.K. Staurosporine was a gift from Dr. H. Nakano, Kyowa Hakko Kogyo Co., Tokyo, Japan, and was dissolved in dimethyl sulphoxide. Indo 1-AM, BCECF-AM and ionomycin were from Calbiochem. 
RESULTS

Comparison of the effect of staurosporine on platelet activation by thrombin with other stimuli
We have previously reported that staurosporine inhibits completely thrombin-induced phosphorylation of a 40 kDa protein, a substrate for protein kinase C, and a 20 kDa protein, a substrate for myosin light-chain kinase, but that it has no effect on the formation of phosphatidic acid, indicating that this inhibitory action does not occur at the level of phospholipase C (Watson et al., 1988) . Essentially, identical results have been observed in the present study with a further platelet stimulant, platelet-activating factor (Table 1) .
We also previously reported (Watson et al., 1988) , and have confirmed in the present study (see below), that (Fig. 1) and also with two further stimulants, ADP and ionophore A23187 (Fig. 1) . In all cases, the shape-change response (reflected by the decrease in light transmission preceding aggregation in Fig. 1 ) was inhibited in the presence of staurosporine, consistent with the inhibition ofmyosin light-chain kinase (Daniel et al., 1984) . In contrast, aggregation induced by phorbol dibutyrate was inhibited completely by staurosporine (Fig. 1) Fig. 2(b) . The increase in cytosolic pH induced by thrombin was reversed in the presence of the Na+-H+ antiport inhibitor EIPA; for example, in the presence of EIPA, thrombin (0.3 unit/ml) decreased the cytosolic pH to 6.93 + 0.01 (n = 5). Similar observations have been previously made by Zavoico et al. (1986) and Siffert & Akkerman (1987) . This decrease in pH was significantly enhanced in the presence of 1 uM-staurosporine to 6.89 +0.01 (P < 0.05; n = 5). On their own, EIPA and staurosporine induced a small decrease of cytosolic pH (< 0.03 in 120 s), or had no apparent effect, respectively. Example traces of these results are shown in Fig. 2(b) .
The actions of EIPA on platelet aggregation and activation of phospholipase C by thrombin were also studied. EIPA had no significant affect on the concentration-response curve for aggregation induced by thrombin. In contrast, in the presence of staurosporine, EIPA inhibited aggregation induced by thrombin, although this effect was highly variable; in some cases complete inhibition was observed, whereas in others aggregation was either delayed or only partially inhibited; representative traces are shown in Fig. 2(a) . EIPA had no effect on the formation of phosphatidic acid by thrombin in the absence or presence of staurosporine ( (Fig. 3) .
Addition of thrombin (0.01-1.0 unit/ml) caused a rapid fall in fluorescence, followed by a slower recovery or partial recovery. This corresponds to a Ca2+ transient with rapidly rising and more slowly declining phases. [Ca2+] is in the micromolar range, Ca2+ being derived from the water used to make the buffer and from glassware etc.) or 2 mM-Ca2 . It is essential for external
[Ca2+] to be greater than 400 nm, since below this concentration the glycoprotein Ilb-Illa complex (i.e. the fibrinogen receptor) splits and platelets are unable to undergo aggregation (Brass et al., 1985) .
The importance of Ca2+ entry was investigated by carrying out experiments in the presence of Ni2+, which has been shown to block the movement of Ca2+ into the platelet (Hallam & Rink, 1985a) . Aggregation induced by thrombin in either the absence or the presence of staurosporine was not altered in the presence of Ni2+.
Thus it appears that Ca2+ entry from the external medium is not required for aggregation; a similar conclusion for thrombin-induced aggregation has been made by Ruda et al. (1988) Fig. 4 . Staurosporine inhibits thrombin-induced aggregation in the absence of Ca2+ mobilization Experiments were carried out in a Born lumi-aggregometer as described in Fig. 2 . Platelets were incubated in buffer containing EGTA (1 mM) and A23187 (300 nM) at 37°C for 60 min. NiCl2 (2 mM), CaCl2 (2 mM) and, where indicated, staurosporine (1 ,UM; St) were added as indicated by the black triangles, and thrombin (1 unit/ml; Thr) or phorbol dibutyrate (PDBu; 400 nM) was added as indicated by the white triangles. The traces are representative of three experiments. mobilization of Ca2+i, but were unable to aggregate because of the low external Ca2+ concentration. After recovery from shape change and the return of [Ca2+]i to resting values, 2 mM-Ca2+ was added and platelets were challenged with thrombin. The continued presence of the Ca21 ionophore prevents the refilling of the intracellular Ca2+ stores . Platelets treated in this manner were still able to undergo aggregation in response to thrombin, albeit at a slower rate than controls. In the presence of staurosporine, aggregation was further slowed but still apparent. These results therefore demonstrate that aggregation can occur in the absence of Ca2+ release from intracellular stores.
In order to examine further the role of [Ca2+] i in the onset of aggregation, however, it is necessary to eliminate Ca2`mobilization from both intra-and extra-cellular sources within the same experiment. This was achieved by combining the above two approaches. As shown in Fig. 4 , the rate of aggregation induced by thrombin was markedly inhibited under these conditions, and aggregation was reminiscent of that by phorbol dibutyrate. Moreover, the thrombin-induced aggregation was fully inhibited by staurosporine (Fig. 4) .
DISCUSSION
Phosphorylation-independent pathway of aggregation
The present study was undertaken to examine the mechanism of aggregation in the presence of the nonspecific inhibitor of protein kinases, staurosporine. Our previous observation (Watson et al., 1988 ) that thrombin induces platelet aggregation, albeit at a lower rate, in the presence of staurosporine (and therefore in the absence of protein phosphorylation) has been extended to additional platelet stimuli, i.e. platelet activating factor, A23187 and ADP. Since these stimuli, unlike thrombin, have no proteolytic activity, it appears that this phosphorylation-independent route of aggregation is not mediated through the proteolytic pathway of platelet activation described by Lapetina etal. (1985) in saponinpermeabilized platelets (whether this pathway is also present in intact platelets is uncertain). The mechanism of platelet activation by platelet-activating factor and by the Ca2" ionophore A23 187 is through the metabolism of Vol. 258 phosphoinositides (Lapetina & Siegel, 1983) and the mobilization of Ca2" (Rittenhouse, 1984) respectively.
The mechanism of ADP-induced aggregation is more controversial. In the presence of cyclo-oxygenase inhibitors, platelet activation by ADP is associated with the mobilization of Ca2"i (Hallam & Rink, 1985b) , but there are contradictory reports as to whether this is associated with the stimulation of phosphoinositide hydrolysis [cf. Fisher et al. (1985) and Sweatt et al. (1986) with Daniel et al. (1986) ].
The present study has considered two potential signalling pathways for the staurosporine-resistant (phosphorylation-independent) aggregation. Siffert & Akkerman (1987) have suggested that low concentrations of thrombin stimulate platelet activation through increased Na+-H+ exchange, leading to alkalinization of the cytosol. In order to test whether this pathway is involved in the staurosporine-resistant aggregation, experiments were carried out in the presence of the Na+-H+ antiport inhibitor EIPA. EIPA decreased, but did not inhibit, aggregation induced by thrombin in the presence of staurosporine, and converted the alkalinization of the platelet cytosol induced by thrombin into an acidification, an effect potentiated by staurosporine. These data therefore demonstrate that aggregation in the presence of staurosporine can occur in the absence of alkalinization of the platelet cytosol, thus ruling out this pathway as the signal for the phosphorylationindependent aggregation. The decreased rate of aggregation observed in staurosporine-treated platelets in the presence of EIPA may be related to potentiation of the EIPA-induced acidification of the cytosol by staurosporine; platelet aggregation is known to be inhibited by a decrease in external pH (Lagarde et al., 1980) , possibly through a corresponding decrease in pHi.
The present study has provided evidence, however, that it is an increase in [Ca2+]i, from both intra-and extracellular sources, which is the signal for the phosphorylation-independent aggregation. Under conditions in which Ca2" mobilization was prevented, the aggregation response to thrombin resembled that to phorbol dibutyrate, and was not fully inhibited by staurosporine. Presumably the mechanism of aggregation by thrombin under these conditions is through the activation of protein kinase C. Phosphorylation-dependent pathway of aggregation Phorbol dibutyrate activates protein kinase C in human platelets and also stimulates secretion and aggregation, responses which occur in the absence of Ca2" mobilization (Rink et al., 1983 protein kinase C and seems to be independent of Ca2l mobilization. The other appears to be through the mobilization of Ca2" and is independent of protein phosphorylation. Aggregation induced by either pathway alone, however, is slower than that which occurs in the presence of both Ca2l mobilization and protein phosphorylation, suggesting that, under physiological conditions, these two pathways interact synergistically. Role of protein kinase C in platelets The present study has also provided information on the various roles of protein kinase C in platelets. have suggested that thrombin stimulates Na+-H+ exchange in platelets through the activation of protein kinase C, since phorbol esters also increase pHi. Zavoico et al. (1986) have emphasized, however, that the increase in pH, induced by phorbol esters is both slower and smaller than that induced by thrombin, making it unlikely that the effects of thrombin are mediated by protein kinase C. We have made similar observations to those of Zavoico et al. (1986) and, in addition, observed staurosporine to have no effect on thrombin-induced alkalinization at concentrations which inhibit fully the activation of protein kinase C. These data strongly suggest that thrombin-induced alkalinization in platelets is not mediated through the stimulation of protein kinase C. A similar conclusion for thrombin-stimulated alkalinization of a smooth-muscle cell line was reached by Berk et al. (1987) , who showed that the down-regulation ofprotein kinase C has no effect on alkalinization induced by thrombin.
The experiments with staurosporine have, however, provided further evidence that protein kinase C has an important physiological role in promoting Ca2" removal from the platelet cytosol. Previously, Pollock et al. (1987) reported that phorbol esters promote Ca2" extrusion from platelets, and Yoshida & Nachmias (1987) described phorbol ester-stimulated Ca2" sequestration into intracellular organelles of platelets. The present study has shown that staurosporine, in concentrations which do not affect platelet Ca2+-ATPase (K. Authi, personal communication) but which fully inhibit protein kinase C, potentiated the Ca2l signal induced by thrombin. In contrast, staurosporine had no effect on the Ca2l transient induced by concentrations of ionomycin which were subthreshold for the activation of protein kinase C.
